Pharmacology & Toxicology · 1997 · 80 citations · 25 references
PharmacyOncologyToxicologyCarcinogenesisComparative ToxicologyEnvironmental ToxicologyCancer RiskCarcinogenic MechanismsCarcinogenicity AssessmentChemical CarcinogenesisMutagenicity AssessmentToxicity ClassificationCancer Risk AssessmentCarcinogen ClassificationCarcinogenic ResponseCorrelationMechanisms Of CarcinogenicityRisk Classification Of CarcinogensSpecies Differences In CarcinogenesisTumor Incidence Analysis
A simplified carcinogenic potency index, the T25, is proposed as a practical method for the inclusion of potency considerations in carcinogen classification systems. The T25 is the chronic daily dose in mg per kg bodyweight which will give 25% of the animals tumours at a specific tissue site, after correction for spontaneous incidence, within the standard life span of that species. Calculated T25 values of a set of 113 US National Cancer Institute/National Toxicology Program (NC/NTP) carcinogens showed excellent correlation (correlation coefficient 0.96, P < 0.0001) with the carcinogenic potency index TD50 of Peto et al. (1984). The mean of T25 values for 51 transspecies, multiple common site NCI/NTP carcinogens were 10-fold lower than those for 62 NCI/NTP single species, single site carcinogens. For these 113 carcinogens, the mean T25 values were approximately 3-fold lower for agents that were also mutagenic in Salmonella compared to the non-mutagenic agents.
25
Prediction of Chemical Carcinogenicity in Rodents from in Vitro Genetic Toxicity Assays
Raymond W. Tennant, Barry H. Margolin, Michael D. Shelby et al. · Science · 1987 · 817 citations
Pharmacy, Genetics, Toxicology +17
Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations.
R L Melnick, J Huff, Billy J. Chou et al. · PubMed · 1990 · 235 citations
Medicine, Oncology, Toxicology +14
Errol Zeiger, Joseph K. Haseman, Michael D. Shelby et al. · Environmental and Molecular Mutagenesis · 1990 · 232 citations
Pharmacy, Genetics, Toxicology +17